REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/18/2025
Back to search
Official data from USPTO
IADC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
08/19/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
02/28/2019
Registration date
08/18/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/18/2020
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Basel, CH
Examiner
LE, KHANH
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NBE-Therapeutics AG
Representatives
Scott D. Marty, J.D., Ph.D. Ballard Spahr LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemicals for use in manufacturing pharmaceuticals; chemicals for use in the pharmaceutical industry; chemical additives for use in the manufacture of pharmaceuticals
Class 5
Pharmaceuticals for the treatment of cancer; pharmaceutical compositions for the treatment of cancer; pharmaceutical drugs for the treatment of cancer; anti-cancer preparations; pharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for human use for suppressing tumors; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for use in oncology
Class 42
Scientific research; medical research services; pharmaceutical research services; pharmaceutical products development; pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
27 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/23/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/23/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/23/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/23/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/23/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/02/2020
PUBO
PUBLISHED FOR OPPOSITION
06/02/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/13/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/23/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/08/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/07/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/19/2019
GNSL
LETTER OF SUSPENSION E-MAILED
11/19/2019
CNSL
SUSPENSION LETTER WRITTEN
11/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/18/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/18/2019
ALIE
ASSIGNED TO LIE
10/17/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/14/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/13/2019
GNRT
NON-FINAL ACTION E-MAILED
05/13/2019
CNRT
NON-FINAL ACTION WRITTEN
05/13/2019
DOCK
ASSIGNED TO EXAMINER
05/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/20/2019
NWAP
NEW APPLICATION ENTERED
03/04/2019
Continuous trademark protection
Get notified about every new filing that threatens IADC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.